FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


15976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some

Members
edetate calcium disodium 1 g/5 mL injection, 6 x 5 mL ampoules
edetate disodium 3 g + sodium ascorbate 15 g injection, 1 vial
edetate disodium 3 g + sodium ascorbate 5 g injection, 1 vial
edetate disodium 3 g / 100 mL + sodium ascorbate 15 g / 100 mL injection, 1 x 100 mL vial (medicinal product pack)
edetate disodium 3 g/100 mL injection, 100 mL vial
edetate disodium 3 g/50 mL + sodium ascorbate 5 g/50 mL injection, 50 mL vial
edetate disodium 3 g injection, 1 vial
edetate disodium 30 mg/mL injection, 10 x 1 mL vials
edetate disodium 500 mg/g + sodium ascorbate 500 mg/g powder for oral liquid, 250 g
edetate disodium 500 mg/g + sodium ascorbate 500 mg/g powder for oral liquid, 500 g
edrophonium chloride 10 mg/mL injection, 1 x 15 mL vial
edrophonium chloride 10 mg/mL injection, 10 x 1 mL ampoules
efalizumab 125 mg injection [4 vials] (&) inert substance diluent [4 x 1.32 mL syringes], 1 pack
efavirenz 200 mg capsule, 42
efavirenz 200 mg capsule, 90
efavirenz 200 mg tablet, 90
efavirenz 30 mg / 1 mL oral liquid, 180 mL (medicinal product pack)
efavirenz 300 mg tablet, 60 tablets (medicinal product pack)
efavirenz 50 mg capsule, 30
efavirenz 50 mg tablet, 30
tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30
tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30
efavirenz 600 mg tablet, 30
eflornithine 11.5% cream, 15 g
eflornithine 11.5% cream, 2 x 30 g
eflornithine 115 mg / 1 g cream, 3.7 g (medicinal product pack)
eflornithine 11.5% cream, 30 g
efmoroctocog alfa 1000 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 1500 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 2000 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 250 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 3000 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 500 units injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack
efmoroctocog alfa 750 international units injection [1 x 750 international unit vial] (&) inert substance diluent [1 x 3 mL syringe], 1 pack (medicinal product pack)
eftrenonacog alfa 1000 units injection [1 vial] (&) inert substance diluent [5 mL syringe], 1 pack
eftrenonacog alfa 2000 units injection [1 vial] (&) inert substance diluent [5 mL syringe], 1 pack
eftrenonacog alfa 250 units injection [1 vial] (&) inert substance diluent [5 mL syringe], 1 pack
eftrenonacog alfa 3000 units injection [1 vial] (&) inert substance diluent [5 mL syringe], 1 pack
eftrenonacog alfa 500 units injection [1 vial] (&) inert substance diluent [5 mL syringe], 1 pack
elasomeran 100 microgram/mL injection, 10 x 2.5 mL vials
elasomeran 200 microgram/mL injection, 10 x 5 mL vials
elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 10 x 2.5 mL vials
elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 10 x 5 mL vials
elbasvir 50 mg + grazoprevir 100 mg tablet, 28
eletriptan 20 mg tablet, 2
eletriptan 20 mg tablet, 30
eletriptan 20 mg tablet, 4
eletriptan 20 mg tablet, 6
eletriptan 40 mg tablet, 1
eletriptan 40 mg tablet, 2
eletriptan 40 mg tablet, 30
eletriptan 40 mg tablet, 4
eletriptan 40 mg tablet, 6
eletriptan 80 mg tablet, 2
eletriptan 80 mg tablet, 30
eletriptan 80 mg tablet, 4
eletriptan 80 mg tablet, 6
elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84
elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84
eliglustat 84 mg capsule, 56 capsules (medicinal product pack)
elosulfase alfa 5 mg/5 mL injection, 5 mL vial
elotuzumab 300 mg injection, 1 vial
elotuzumab 400 mg injection, 1 vial
eltrombopag 12.5 mg tablet, 14
eltrombopag 12.5 mg tablet, 28
eltrombopag 12.5 mg tablet, 84
eltrombopag 25 mg powder for oral liquid, 30 sachets
eltrombopag 25 mg tablet, 28
eltrombopag 50 mg tablet, 28
eltrombopag 75 mg tablet, 28
emicizumab 105 mg/0.7 mL injection, 0.7 mL vial
emicizumab 150 mg/mL injection, 1 mL vial
emicizumab 30 mg/mL injection, 1 mL vial
emicizumab 60 mg/0.4 mL injection, 0.4 mL vial
empagliflozin 10 mg + linagliptin 5 mg tablet, 10
empagliflozin 10 mg + linagliptin 5 mg tablet, 30
empagliflozin 10 mg tablet, 10
empagliflozin 10 mg tablet, 30
empagliflozin 12.5 mg + metformin hydrochloride 1 g tablet, 14
empagliflozin 12.5 mg + metformin hydrochloride 1 g tablet, 60
empagliflozin 12.5 mg + metformin hydrochloride 500 mg tablet, 14
empagliflozin 12.5 mg + metformin hydrochloride 500 mg tablet, 60
empagliflozin 12.5 mg + metformin hydrochloride 850 mg tablet, 14
empagliflozin 12.5 mg + metformin hydrochloride 850 mg tablet, 60
empagliflozin 25 mg + linagliptin 5 mg tablet, 10
empagliflozin 25 mg + linagliptin 5 mg tablet, 30
empagliflozin 25 mg tablet, 10
empagliflozin 25 mg tablet, 30
empagliflozin 5 mg + metformin hydrochloride 1 g tablet, 14
empagliflozin 5 mg + metformin hydrochloride 1 g tablet, 60
empagliflozin 5 mg + metformin hydrochloride 500 mg tablet, 14
empagliflozin 5 mg + metformin hydrochloride 500 mg tablet, 60
empagliflozin 5 mg + metformin hydrochloride 850 mg tablet, 14
empagliflozin 5 mg + metformin hydrochloride 850 mg tablet, 60
emtricitabine 200 mg + rilpivirine 25 mg + tenofovir alafenamide 25 mg tablet, 30
tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + rilpivirine 25 mg tablet, 30
emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30
emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet, 30
tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30
tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30
tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 100

Start Previous Page 63 of 160 Next End


Reference Sets

Reference set descriptor

Back to Start